Kandu’s IpsiHand BCI improves chronic stroke arm function in randomized trial, but 17 control patients dropping out matters
The 85-patient BCI-REHAB study found a 4.5-point treatment difference favoring IpsiHand and a number needed to treat of 2.2, although substantial control-group withdrawal complicates interpretation.